Variation in Provision of Collaborative Medication Reviews on Entry to Long-Term Care Facilities

Janet K. Sluggett, J. Simon Bell, Catherine Lang, Megan Corlis, Craig Whitehead, Steve L. Wesselingh, Maria C. Inacio

Research output: Contribution to journalArticlepeer-review

14 Citations (Scopus)


Objectives: Residential medication management reviews (RMMRs) are comprehensive medication reviews conducted by clinical pharmacists and general medical practitioners. RMMRs are the primary government-funded service to optimize medication management in Australian residential aged care facilities (RACFs) and are recommended for all new residents. This study investigated resident characteristics associated with timely RMMR provision within 90 days of RACF entry and national intrafacility variation in timely RMMR provision. Design: National retrospective cohort study. Setting and Participants: Individuals aged ≥65 years who first entered permanent residential aged care in Australia between January 1, 2012, and December 31, 2015, received at least 1 medication in the previous year, and were alive at 90 days post-RACF entry. Methods: Resident characteristics associated with timely RMMR provision were determined using multivariate logistic regression. Crude and risk-adjusted funnel plots were used to examine intrafacility variation in timely RMMR provision. Results: Of the 143,676 residents from 2799 RACFs included, 30,883 (21.5%) received an RMMR within 90 days. Resident characteristics associated with timely provision included dementia (adjusted odds ratio [aOR] 1.05, 95% confidence interval [CI] 1.02–1.08), primary language other than English (aOR 1.04, 95% CI 1.01–1.09), number of unique prescriptions dispensed in the previous year (aOR [per additional 5 prescriptions] 1.02, 95% CI 1.01–1.03), need for medication administration assistance (aORs ranged from 1.35 to 1.42, compared with residents self-managing) and facility remoteness (aORs ranged from 0.67 to 0.75 for residents outside major cities). The proportion of new residents receiving a timely RMMR ranged from 0% (n = 303 RACFs) to 100% (n = 4 RACFs). There were 174 RACFs (6.2%) in which ≥50% of new residents received a timely RMMR. Conclusions and Implications: Although there was some evidence that RMMRs are targeted to individuals with a greater burden of medication use and those living with dementia, considerable variation in provision exists nationally. This flagship medication review service is generally underutilized among residents of Australian RACFs.

Original languageEnglish
Pages (from-to)148-155.e1
Number of pages8
JournalJournal of the American Medical Directors Association
Issue number1
Publication statusPublished - Jan 2021


  • Australia
  • long-term care
  • medication management
  • Medication review
  • nursing homes
  • residential aged care


Dive into the research topics of 'Variation in Provision of Collaborative Medication Reviews on Entry to Long-Term Care Facilities'. Together they form a unique fingerprint.

Cite this